Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Emblem Corp EMMBF

Healthcare Biotechnology Cannabis
"Emblem Corp is a licensed producer of medical cannabis. It is intended to cultivate and cure cannabis for medicinal use. The group operates in the business segment of production and sale of medical cannabis."


OTCPK:EMMBF - Post by User

Emblem Corp > < $1.00
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Valkrie99on Jul 18, 2018 10:39am
52 Views
Post# 28332453

RE:RE:RE:RE:RE:RE:< $1.00

RE:RE:RE:RE:RE:RE:< $1.00You realize that this isn't the only thing the EMC will make money on.
They actually are able to generate some rev while expanding the pharma division--which will be the next thing.  
They are evolving into a different type of business and now is the time to do it.
It is quite obvious that this is their plan after seeing the last move.

Smart investors will be getting into this cash rich company not for what you have mentioned but for the potential that exists with the development of pharma products--John Stewart will be instrumental.

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities